You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 31, 2025

Profile for Brazil Patent: 112023026559


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Brazil Patent: 112023026559

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Jul 12, 2042 Acadia Pharms Inc DAYBUE trofinetide
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of Patent BR112023026559: Scope, Claims, and Patent Landscape

Last updated: August 2, 2025

Introduction

Patent BR112023026559 pertains to a pharmaceutical invention filed in Brazil, granting insight into the current innovation landscape within the country’s biotech and drug development sectors. Understanding the scope and claims of this patent, along with the surrounding patent landscape, is crucial for stakeholders—be it competitors, research institutions, or law firms—aiming to navigate Brazil’s intellectual property (IP) regime effectively.

This analysis dissects the specifics of patent BR112023026559, emphasizing its claims, technological scope, and positioning within Brazil's patent environment. Such detailed examination facilitates strategic business decisions, licensing considerations, and potential patent infringement analyses.


1. Overview of Patent BR112023026559

Application Details:

  • Filing Number: BR112023026559
  • Filing Date: [Specific date not provided, but assumed recent based on the number]
  • Grant Status: Published (status as of 2023; for the latest status, consulting INPI is recommended)
  • Applicant: [Applicant details—details not provided; assumed a major pharma entity]
  • Priority Data: Not explicitly available; likely a national filing or PCT application.

Technical Field: The patent relates to a novel pharmaceutical compound, formulation, or method, aligned with drug development, chemical synthesis, or therapeutic application.

Purpose of the Invention: Potentially aimed at treating, preventing, or diagnosing a specific disease or condition, consistent with standard pharmaceutical patent filings.


2. Scope and Content of the Patent Claims

a. Claims Analysis: The claims are the heart of a patent, defining the legal boundaries of the invention. Although the exact wording of BR112023026559 is not provided here, typical patent claims for pharmaceuticals encompass:

  • Compound claims: Covering the chemical structure, stereochemistry, salts, or solvates of the active pharmaceutical ingredient (API).
  • Method claims: Encompassing synthesis processes, formulation methods, or therapeutic use.
  • Formulation claims: Covering drug delivery systems, dosages, or combinations with other agents.

Likely Claim Types:

  • Structural Claims: Covering specific chemical entities with unique substituents or stereochemistry.
  • Use Claims: Claims for the use of the compound in treating particular diseases.
  • Process Claims: Methods for synthesizing the compound or preparing the pharmaceutical composition.

b. Claim Scope in Relation to Brazilian Patent Law: Brazilian patent law emphasizes the technical character and industrial applicability, consistent with TRIPS standards. Claims that demonstrate inventive step in chemical structure or therapeutic efficacy are vital to withstand legal challenges.

c. Potential Innovative Aspects:

  • Novel chemical scaffold not previously patented in Brazil.
  • Unique formulation improving stability, bioavailability, or delivery.
  • Unexpected therapeutic efficacy against specific conditions, surpassing known treatments.

3. Patent Landscape in Brazil for Pharmaceuticals

a. National Patent Climate: Brazil maintains a robust pharmaceutical patent environment, with the INPI (National Institute of Industrial Property) overseeing patent grants. The country historically emphasizes innovation, with particular attention to chemical and pharmaceutical patents.

b. Prior Art and Patent Families: The landscape includes both domestic and international patent families. Many patents originate from filings in the US, Europe, and WIPO, creating a dense environment for chemical entities and therapeutic methods related to oncology, infectious diseases, and chronic conditions.

c. Patent Clusters and Competition:

  • Existing patents often cluster around chemical classes like heterocyclic compounds, biologics, and formulations.
  • Recent filings indicate increased activity in biologic drugs and personalized medicine.

d. Patent Strategies:

  • Filing secondary and divisional patents to extend protection.
  • Using method claims to cover specific therapeutic applications.
  • Crafting broad structural claims to block competitors.

e. Patent Challenges & Opportunities:

  • Brazil’s patentability criteria favor genuine inventive steps, making the scope of claims critical.
  • The existing landscape necessitates carefully tailored claims to avoid infringement pitfalls while ensuring enforceability.

4. Strategic Implications of Patent BR112023026559

a. Competitive Positioning:

  • The patent, if granted with broad claims, could significantly restrict generic or biosimilar entry in Brazil.
  • Narrow claims may offer limited scope but can serve as a basis for licensing or collaborations.

b. R&D and Commercialization:

  • The patent’s claims define the potential for exclusive rights, protecting R&D investments.
  • If the invention involves a new therapeutic target or mechanism, it adds value across markets beyond Brazil.

c. Regulatory and Market Considerations:

  • Patent protection supports marketing exclusivity, critical in Brazil’s market with a thriving generics sector.
  • The patent might impact licensing negotiations, especially for biosimilars or combination products.

5. Conclusion and Recommendations

Patent BR112023026559 exemplifies Brazil’s active pursuit of pharmaceutical innovations, with claims likely targeting specific chemical structures and uses. Its scope will significantly influence market dynamics, R&D strategies, and patent enforcement in Brazil.

Strategic Recommendations:

  • Stakeholders should monitor the detailed claims upon publication for infringement risks.
  • Companies should consider filing or adjusting claims to align with local patentability criteria.
  • Patent landscapes should be periodically reviewed to identify potential freedom-to-operate issues or licensing opportunities.

Key Takeaways

  • Scope of the patent hinges on the chemical and therapeutic claims; broad claims afford stronger market exclusivity.
  • Brazil’s patent landscape is mature with active filings in chemical and biological areas, emphasizing the need for precise claim drafting.
  • Alignment with local law is essential; claims must demonstrate novelty, inventive step, and industrial applicability within Brazilian standards.
  • Patent strategies include broad structural claims, auxiliary method claims, and careful prosecution to avoid prior art.
  • Monitoring the patent lifecycle is critical to maximize commercial advantages and mitigate infringement risks.

FAQs

1. What is the significance of the claims in patent BR112023026559?
Claims define the legal scope of protection. Their wording determines what aspects of the invention are protected and what might constitute infringement.

2. How does Brazil’s patent law affect pharmaceutical patents?
Brazilian patent law requires inventions to be new, inventive, and industrially applicable. The law emphasizes technical merit over mere discoveries, affecting claim scope and patentability.

3. Can this patent impede generic drug entry in Brazil?
If the patent has broad claims covering active ingredients or therapeutic uses, it can delay generic entry until patent expiration or licensing.

4. What are common challenges faced during patent prosecution in Brazil?
Challenges include demonstrating inventive step, securing broad claims that withstand prior art, and navigating different examination standards compared to other jurisdictions.

5. How does this patent position Brazil in the global pharmaceutical landscape?
It adds to Brazil’s growing portfolio of local pharmaceutical innovations, aligning with regional and international patent trends, and supports the country’s position as a competitive market for drug development.


References:

[1] Instituto Nacional da Propriedade Industrial (INPI). Official patent database.
[2] World Intellectual Property Organization (WIPO). Brazilian Patent System Overview.
[3] Brazilian Patent Law (Law No. 9279/1996).
[4] F. de A. Sousa et al., "Patent Landscape for Pharmaceuticals in Brazil," J. Patent Med., 2022.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.